ORTHO-LEFLUNOMIDE (25 mg) (N-(2'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)

ORTHO-LEFLUNOMIDE (25 mg) (N-(2′-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)

In Stock

Ready to ship

Catalogue No.

1A06120

CAS No.

1403564-06-6

Molecular Formula

C₁₂H₉F₃N₂O₂

Product Type

Pharmaceutical Analytical Impurities

$650.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F231X0

Harmonized System (HS) Code *:

29349910

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₁₂H₉F₃N₂O₂

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F231X0	1A06120-F231X0	See Product Information Sheet	India	Chemical Synthesis


Lot No F231X0	USP Certificates/Product Information Sheets and Valid Use Dates 1A06120-F231X0
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* Chemical Synthesis

Lot No

F231X0

USP Certificates/Product Information Sheets and Valid Use Dates

1A06120-F231X0

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Frequently bought together

ORTHO-LEFLUNOMIDE (25 mg) (N-(2'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)

Catalogue No.

1A06120

CAS No.

1403564-06-6

Molecular Formula

C₁₂H₉F₃N₂O₂

Product Type

Pharmaceutical Analytical Impurities

$650.00

4-METHOXY ITRACONAZOLE DERIVATIVE (25 mg) (2-sec-Butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one)

Catalogue No.

1A06380

CAS No.

252964-68-4

Molecular Formula

C₂₃H₂₉N₅O₂

Product Type

Pharmaceutical Analytical Impurities

$650.00

ROSUVASTATIN ETHYL ESTER (25 mg) (Ethyl (3R,5S,6E)-7-[4-(4- fluorophenyl)-2-(Nmethylmethanesulfonamido)- 6-(propan-2-yl)pyrimidin-5-yl]- 3,5-dihydroxyhept-6-enoate)

Catalogue No.

1A06130

CAS No.

851443-04-4

Molecular Formula

C₂₄H₃₂FN₃O₆S

Product Type

Pharmaceutical Analytical Impurities

$725.00

2-AMINO DAPSONE ISOMER (25 mg) (2-[(4-Aminophenyl)sulfonyl]aniline)

DICLOFENAC BENZALDEHYDE (25 mg) (2-[(2,6-Dichlorophenyl)amino]benzaldehyde )

NAPROXEN ETHYL ESTER (25 mg) ((S)-Ethyl 2-(6-methoxynaphthalen-2-yl)propanoate)

CHLORO NAPROXEN (25 mg) ((S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic acid)

AMINOFLUCONAZOLE QUATERNARY MESYLATE (25 mg) (4-Amino-1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-4H-1,2,4-triazolium methanesulfonate)

DESAMINO DAPSONE (25 mg) (4-(Phenylsulfonyl)aniline)

EPI LOVASTATIN (25 mg) ((1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2R)-2-methylbutanoate )

AMISULPRIDE ACID (25 mg) (2-Methoxy-4-amino-5-ethylsulfonyl benzoic acid)

METRONIDAZOLE ACID (25 mg) (2-(2-Methyl-5-nitroimidazol-1-yl)acetic acid)